Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Vera Fridman, MD joins the CMTA STAR Advisory Board
…and Associate Director of Medical Student Education for the Department of Neurology. Dr. Fridman has a long-standing clinical and research interest in peripheral neuropathy, her research to date has focused…
CMTA Seed Money Draws NIH Support For Type 2 Gene Editing
…the CMTA’s research efforts are consolidated under the banner of STAR—which brings together the world’s largest network of biotech research partners, research scientists, clinicians and patients—and funds more CMT grants…
CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship
…experience in all aspects of clinical research related to inherited neuropathies. Conduct an in-depth research project aligned with their specific interests. Train at one of the INC’s premier research centers,…
CMT2F Natural History Study Nears Full Recruitment as Biomarker Analysis Begins
…Iowa coordinator at CMTRes@healthcare.uiowa.edu to become the final participant. Register with Patients as Partners in Research Today Not yet registered with Patients as Partners in Research? Click the button below…
Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence
…soon contact our Patients as Partners in Research who match the study criteria for NMD Pharma’s SYNAPSE-CMT trial. CMTA will contact only those who consent to receive research opportunity notifications….
Community Partnership Opportunities
…to present 2-3 levels of our overall proposal to a potential sponsor. Do your research on what they have given to other charities locally and pick the levels you feel…
Bracing for CMT
…care for people living with CMT. Click here to find a clinic near you. Kinetic Research Kinetic Research is an Orthotic Prosthetic technology company that specializes in the application of…
The CMTA Report Summer 2024_FOR GUIDES AND BROCHURES DOWNLOAD
…Research Officer In “Under the Microscope,” CMTA Chief Research Officer, Katherine Forsey, PhD, takes a closer look at topics related to CMTA’s Strategy To Accelerate Research (STAR). Dr. Forsey oversees…
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A
…philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with pharmaceutical and biotechnology companies…